Skip to content
  • Pipeline
    • Overview
      • Stenoparib
      • External Programs
    • Clinical Trials
  • Medical Laboratory
    • DRP Cancer Tests​
    • Gene Expression Profiling
    • The DRP software
    • Order Process
    • Contact
  • Technology
    • The DRP® Method
    • Scientific Publications
  • About Us
    • Overview
    • Leadership
    • Board of Directors
    • Scientific Advisory Board
    • Partnering
  • Investors
    • Overview
    • News
    • Stock Info
    • Financials
    • Governance
    • Resources
    • Presentations
  • Contact
    • General Inquires
  • Careers
    • Join Allarity
  • Pipeline
    • Overview
      • Stenoparib
      • External Programs
    • Clinical Trials
  • Medical Laboratory
    • DRP Cancer Tests​
    • Gene Expression Profiling
    • The DRP software
    • Order Process
    • Contact
  • Technology
    • The DRP® Method
    • Scientific Publications
  • About Us
    • Overview
    • Leadership
    • Board of Directors
    • Scientific Advisory Board
    • Partnering
  • Investors
    • Overview
    • News
    • Stock Info
    • Financials
    • Governance
    • Resources
    • Presentations
  • Contact
    • General Inquires
  • Careers
    • Join Allarity

Newsroom: Top News

Top News       |       All News

Allarity Therapeutics Announces Strategic Capital Allocation for Filing of SPAC Registration Statement

Sep 11, 2026
Read More

Allarity Therapeutics Reports Second Quarter 2026 Results and Completion of the Phase 3-Ready Stenoparib Manufacturing Campaign

Aug 14, 2026
Read More

Allarity Therapeutics Announces CLIA Certification, Clearing the Path for Advancing DRP® Testing for FDA Registration

Jul 07, 2026
Read More

Pipeline
Overview
– Stenoparib– External Programs
– Clinical Trials

Technology
 The DRP® Platform
Scientific Publications
About Us
Overview
Leadership
Board of Directors
SAB
Partnering
Investors
Overview
News 
Stock Info
Financials
Governance Resources
Presentations
Newsroom
 News
Media Contact

Contact
General Inquires

Careers
Join Allarity

Copyright © 2026 Allarity Therapeutics, Inc. All Rights Reserved.

Unless otherwise specified, all product and service name appearing in this internet site are trademark owned by or licensed to Allarity, its subsidiaries or affiliates. No use of any Allarity trademark, trade name, or trade dress in this site may be made without the prior written authorization of Allarity, except to identify the product or services of company.

Terms of Use 

Privacy Policy

Social Media Policy

Cookie Policy

United States:
123 E Tarpon Ave
Tarpon Springs, FL 34689
USA
Tel. +1 401-426-4664

Denmark:
Venlighedsvej 1
2970 Hoersholm
Denmark
Tel. +45 88 74 24 14
CVR: 34623562